A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

PHASE3CompletedINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Head Lice Infestation
Interventions
DRUG

Abametapir Lotion 0.74% w/w

Abametapir Lotion 0.74% was dispensed to subjects on Day 0 for self-administration at home on the same day.

DRUG

Vehicle Lotion

Vehicle Lotion was dispensed to subjects on Day 0 for self-administration at home on the same day.

Trial Locations (7)

33407

LSRN Reserach, West Palm Beach

38201

McKenzie Medical Center, McKenzie

44122

Haber Dermatology, Beachwood

78229

Radiant reserach Inc., San Antonio

89106

Impact Clinical Trials, Las Vegas

90036

Axis Clinical Trials, Los Angeles

93618

Universal Biopharma Reserach INC, Dinuba

All Listed Sponsors
collaborator

Accelovance

INDUSTRY

collaborator

Syneos Health

OTHER

lead

Dr. Reddy's Laboratories Limited

INDUSTRY

NCT02060903 - A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation | Biotech Hunter | Biotech Hunter